Revotek o phatlalalitse hore e fumane tumello ho tsoa ho Khomishene ea Naha ea Bophelo bo Botle ea Chaena ho qala boithuto ba bongaka Sepetleleng sa West China, Chengdu, ka sehlahisoa sa eona sa pele sa stem cell 3D bioprinting, REVOVAS.
"Tlhaloso e tšoaea mohato oa bohlokoa bakeng sa Revotek. Re thabetse ho ntšetsa pele REVOVAS, sehlahisoa sa rona sa pele sa stem cell 3D bioprinting bakeng sa bakuli ba nang le Peripheral Artery Diseases (PADs), 'me re tšepa hore thuto e tlang e tla sebetsa e le tiiso ea sethala sa rona sa stem cell 3D bio-printing ka kakaretso, "ho boletse joalo. Mme Yin Xie, CEO oa Revotek, "Phuputso ena ea pele e tla thusa ho tseba tšireletseho le katleho e ka bang teng ea sethala sa khatiso sa stem cell 3D biological, 'me e tla tšoaea sebaka sa eona e le sethala se secha sa autologous stem-cell-therapy ho fana ka liphekolo tse nchafatsang. mefuta e mengata ea mafu a sa foleng, a fihlang ho bakuli ba nang le mafu a sa tšoaneng a pelo, le ba bang ba bangata, ka phekolo ena e fetolang bophelo. “
Tumello e lumella thuto ea kliniki ho lekola polokeho ea REVOVAS ho batho ba nang le li-PAD. Revotek o lebelletse ho qala thuto ea bongaka ka Q2 2022.
SEO U LOKELANG HO SE NKA HO SEHLOOHO ENA:
- Said Ms Yin Xie, CEO of Revotek, “This initial study will help determine the safety and potential effectiveness of the stem cell 3D biological printing platform, and will mark its place as a new autologous stem-cell-therapy platform to provide regenerative therapies for a range of chronic diseases, reaching patients with various cardiovascular diseases, and many others, with this life-changing therapy.
- We are excited to advance REVOVAS, our first stem cell 3D bioprinting product for patients with Peripheral Artery Diseases (PADs), and we hope that the upcoming study will serve as validation of our stem cell 3D bio-printing platform as a whole,”.
- Revotek o phatlalalitse hore e fumane tumello ho tsoa ho Khomishene ea Naha ea Bophelo bo Botle ea Chaena ho qala boithuto ba bongaka Sepetleleng sa West China, Chengdu, ka sehlahisoa sa eona sa pele sa stem cell 3D bioprinting, REVOVAS.
